Dihydroergotamine (Dihydergot) in the treatment of orthostatic circulatory disorders: a double-blind comparison with placebo.

Suppr

超能文献

作者信息

Krüger K, Neff K

出版信息

J Med. 1973;4(2):106-17.

PMID:4584070

Abstract

摘要

相似文献

Dihydroergotamine (Dihydergot) in the treatment of orthostatic circulatory disorders: a double-blind comparison with placebo.

J Med. 1973;4(2):106-17.

[Dihydroergotamine in orthostatic dysregulation].[二氢麦角胺与体位性调节障碍]

Med Klin. 1971 Apr 16;66(16):601-4.

[Effect of intramuscular dihydroergotamine on blood circulation in the early postoperative phase. A clinical study].[肌内注射双氢麦角胺对术后早期血液循环的影响。一项临床研究]

Med Klin. 1976 May 28;71(22):961-5.

[Orthostatic dysregulations in hypertensive patients].

Munch Med Wochenschr. 1967 Jan 27;109(4):176-80.

[Orthostatic hypotension. An attempt to simplify diagnosis -- treatment with dihydergot in general practice(author's transl)].[直立性低血压。在一般实践中简化诊断的尝试——用双氢麦角胺治疗（作者译）]

Schweiz Rundsch Med Prax. 1975 Jun 10;64(23):730-4.

[Evaluation of the effectiveness of Thomasin (etilefrin) in hypotensive and/or orthostatic circulatory disorders in comparison with pholedrine and placebo (double-blind study)].[与去氧肾上腺素和安慰剂相比，托马辛（依替福林）治疗低血压和/或体位性循环障碍的疗效评估（双盲研究）]

Z Arztl Fortbild (Jena). 1982 Feb 15;76(4):149-53.

[The effect of etilefrine and dihydroergotamine on sympathetic nervous system activity when standing up (author's transl)].

Dtsch Med Wochenschr. 1978 Sep 29;103(39):1513-7. doi: 10.1055/s-0028-1129292.

A controlled study with Dihydergot on patients with orthostatic dysregulation.一项使用双氢麦角碱对体位性调节障碍患者进行的对照研究。

Cardiology. 1976;61 suppl 1:333-41. doi: 10.1159/000169827.

[Treatment of hypotensive circulatory dysregulation with a combination of dihydroergotamine and etilefrine (author's transl)].双氢麦角胺与恢压敏联合治疗低血压性循环调节障碍（作者译）

MMW Munch Med Wochenschr. 1981 Jan 30;123(5):177-80.

[Treatment of orthostatic hypotension due to major hypotensive drugs (exception of ganglioplegics). Trial of dihydroergotamine].

Nouv Presse Med. 1973 Jun 30;2(26):1761-4.

引用本文的文献

Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.双氢麦角胺的主要代谢产物8'-羟基双氢麦角胺对人体静脉收缩作用的研究。

Eur J Clin Pharmacol. 1984;26(2):239-42. doi: 10.1007/BF00630292.

Effects of dihydroergotamine (DHE) on blood flow and metabolism in the underperfused myocardium in anaesthetized dogs.双氢麦角胺（DHE）对麻醉犬灌注不足心肌血流及代谢的影响。

Basic Res Cardiol. 1984 Jul-Aug;79(4):461-8. doi: 10.1007/BF01908147.

Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing.二氢麦角胺急性和慢性口服给药期间的血管收缩活性与其药代动力学之间的关系。

Eur J Clin Pharmacol. 1986;30(6):685-9. doi: 10.1007/BF00608216.

The effects of nitroglycerin on exercise-induced regional myocardial contractile dysfunction are not diminished by pretreatment with dihydroergotamine.二氢麦角胺预处理不会减弱硝酸甘油对运动诱发的局部心肌收缩功能障碍的作用。

Br J Pharmacol. 1987 Sep;92(1):87-95. doi: 10.1111/j.1476-5381.1987.tb11299.x.

Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjects.

Eur J Clin Pharmacol. 1991;41(6):597-602. doi: 10.1007/BF00314992.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验